Foundation Medicine's Revenues Grow 39 Percent in Q4, Net Loss Widens | GenomeWeb

This article has been updated with information and comments from Foundation Medicine's earnings call.

NEW YORK (GenomeWeb) – Foundation Medicine reported a 39 percent increase in fourth quarter revenues after the close of market on Tuesday, driven by strong growth from its pharmaceutical business.

The Cambridge, Massachusetts-based firm booked $26.1 million in fourth quarter revenues, up from $18.7 million a year ago, and narrowly beating the consensus Wall Street estimate of $25.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.